The Drug Controller General of India (DGCI) today gave a nod to the use of both Oxford-AstraZeneca Covishield and Bharat Biotech’s Covaxin to be used for immunization against Covid-19. The development comes after an expert panel of the Central Drugs Standard Control Organisation (CDSCO) recommended them for emergency use.
Soon after approval, Prime minister Narendra Modi presented his gratitude towards doctors, medical staff, scientists, and all corona warriors for their outstanding work in such critical times. PM stated the approval as a turning point and tweeted, “It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfill the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion.”
In another big development, The Indian Council of Medical Research (ICMR) on Saturday also claimed that the National Institute of Virology, Pune, has successfully cultured the new variant of coronavirus from the clinical samples collected from the UK-returnees.
ICMR also mentioned that apart from the UK and India no other country has yet reported successful isolation and culture of the UK-variant of SARS-CoV-2.
ICMR released the information through a tweet from their official Twitter handle and said Vero cell lines were used by the scientists of ICMR-NIV to culture the UK-variant of the virus.
A new strain was registered and identified in Uk that is reportedly 70% more transmissible than existing strains. India has till now detected 29 cases of the mutant strain. All 29 patients have been identified and kept in isolation.